Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt - Wikidata - wikimedia - TriplyDB

Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt

Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt

http://www.wikidata.org/entity/Q36728127

about

Sirtuins: molecular traffic lights in the crossroad of oxidative stress, chromatin remodeling, and transcription Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells Biochemical effects of SIRT1 activators Calorie restriction and the exercise of chromatin Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis Cancer Clocks Out for Lunch: Disruption of Circadian Rhythm and Metabolic Oscillation in Cancer Regulation and function of AMPK in physiology and diseases Emerging therapeutic roles for NAD(+) metabolism in mitochondrial and age-related disorders SIRT1: A Novel Target for the Treatment of Muscular Dystrophies Diabetic complications within the context of aging: Nicotinamide adenine dinucleotide redox, insulin C-peptide, sirtuin 1-liver kinase B1-adenosine monophosphate-activated protein kinase positive feedback and forkhead box O3 Erythropoietin and diabetes mellitus Dysregulated metabolism contributes to oncogenesis Protective effects and mechanisms of sirtuins in the nervous system Regulation of satellite cell function in sarcopenia SIRT1 as a therapeutic target in inflammaging of the pulmonary disease Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)?The role of mammalian sirtuins in the regulation of metabolism, aging, and longevity NAD+ as a signaling molecule modulating metabolism Metabolic reprogramming as a novel regulator of skeletal muscle development and regeneration Regulation of cell survival and death by pyridine nucleotides Undercover: gene control by metabolites and metabolic enzymes From Nutrient to MicroRNA: a Novel Insight into Cell Signaling Involved in Skeletal Muscle Development and Disease New Insights for Oxidative Stress and Diabetes Mellitus Longevity and skeletal muscle mass: the role of IGF signalling, the sirtuins, dietary restriction and protein intake A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol Sirtuin deacylases: a molecular link between metabolism and immunity Slowing ageing by design: the rise of NAD(+) and sirtuin-activating compounds Mitochondrial dysfunction in neurodegenerative diseases The physiological roles of Sirt1 in skeletal muscle The effects of obesity on skeletal muscle regeneration Wld(S) reduces paraquat-induced cytotoxicity via SIRT1 in non-neuronal cells by attenuating the depletion of NAD Reversible acetylation of the chromatin remodelling complex NoRC is required for non-coding RNA-dependent silencing Cilostazol Modulates Autophagic Degradation of β-Amyloid Peptide via SIRT1-Coupled LKB1/AMPKα Signaling in Neuronal Cells Nitrite activates AMP kinase to stimulate mitochondrial biogenesis independent of soluble guanylate cyclase AMP-activated protein kinase regulates nicotinamide phosphoribosyl transferase expression in skeletal muscle A potent and selective small molecule inhibitor of sirtuin 1 promotes differentiation of pluripotent P19 cells into functional neurons Regulation of exercise-induced fiber type transformation, mitochondrial biogenesis, and angiogenesis in skeletal muscle

P2860

Q21296795-C9CF5283-3D5D-42A9-B8D4-E7948A7A9653 Q24314812-F1D136A8-F8C7-409D-9428-3A9CAE08D29F Q24595845-95D49C19-296D-4D76-BBDE-A48B87843646 Q24608197-D587F5CA-7DAC-4679-9CAD-62EA36185BE7 Q24633565-A4FFFA22-9EBE-494E-BAC3-32D3D3066254 Q24633830-858DD09F-9DE1-4575-80EF-D35E0BCD43C9 Q24652611-AE9FFEFA-F653-4D56-BA1B-E07552F41334 Q24658408-2EE8CC47-60BC-4D27-9E43-F4940CC0F36C Q26738550-DE22ECC4-6664-40B0-9BA9-9DFFF6FF3679 Q26740291-04778A4C-9DD6-44D1-8C39-5EE65CEA3FE0 Q26741300-1E944047-A31F-497E-AB79-4A2568AC69FD Q26748736-1BC4EEB5-DBC8-4CED-822A-EA38B07519C9 Q26749486-964EF136-B009-4FF1-9D8C-A135D042244B Q26777878-6A10DB3F-4AED-456F-9CC1-569ADB2E5060 Q26784630-7053B1AC-4991-4843-B0D7-E585C8AAD322 Q26825585-D92E29ED-4DDA-489D-BC59-1BD907F1F23D Q26826890-4D9C3ED1-C3D2-478A-83BF-391E901534D6 Q26829351-82D0FDE5-6C66-4146-939A-8C17338C5ED4 Q26864685-28160870-0426-4BF2-A9B3-960B6C456ED1 Q26865526-A6503D7A-7780-45D4-8B7F-DCA462F09911 Q26995735-A42B5D68-D0AD-4A03-833F-5AE2E65370BD Q27002421-CE6F4B36-B7B4-4FA5-9DFA-C75C04B54E7E Q27026075-65B22206-3518-4CA6-A64E-3FA249D4B0B5 Q28072281-C3915CF4-1415-4555-A399-7FC9CDDE8889 Q28080060-6DC2FC3E-80BE-497D-9F73-E0508EACA1AB Q28080679-1AB3B353-BF9C-47F4-AC84-277A2B52F35C Q28083422-427BD345-DBE2-424F-8FCB-EA4574C3A8C0 Q28254419-3E7A2C65-F0C3-41AB-AE16-30EA7E930877 Q28283588-0F3D343F-4136-4189-AA79-7F9F7F0F8925 Q28314993-0DA16705-2DA7-481E-8B79-3C972C45549F Q28387647-954441E7-A506-47C3-9FA0-2CBA691A33CC Q28389469-8EF68A14-DEED-4B79-91FB-EFE4FB17AE15 Q28393087-3E724051-C954-4954-B8B7-060BDA219100 Q28478925-459F82AD-2601-4C4E-974C-37717C07F41D Q28508559-EA6BAB1F-6C4B-4ECC-A116-E75BBE5E4B1C Q28553396-8AA8BF1F-36F0-4B1D-84DB-C0FB2E2A0B58 Q28579907-6AD6A97D-A0A9-4B50-BC72-A2B0F11C9AD3 Q28592195-E8BCB79A-BF55-4804-94A0-FA957CD443BD Q28828567-84875370-E685-4E61-854B-929F2A8B3665 Q30428955-C3E47920-238F-4305-8E43-9B28ADFDF849

P2860

Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt

http://www.wikidata.org/entity/Q36728127

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Glucose restriction inhibits s ...... K-mediated regulation of Nampt

@ast

Glucose restriction inhibits s ...... K-mediated regulation of Nampt

@en

type

label

Glucose restriction inhibits s ...... K-mediated regulation of Nampt

@ast

Glucose restriction inhibits s ...... K-mediated regulation of Nampt

@en

prefLabel

Glucose restriction inhibits s ...... K-mediated regulation of Nampt

@ast

Glucose restriction inhibits s ...... K-mediated regulation of Nampt

@en

P1433

Q36728127-2E887D57-481D-474A-A7DD-E5FE9A5A8172

P1476

Q36728127-3342E3AA-4774-42AC-B073-903753B71C8B

P2093

Q36728127-0F6F56A4-7155-495A-9479-1E824AA97D2B

Q36728127-1F71877E-5799-4CB5-8038-963EC5BFB79F

Q36728127-24F708D9-07C3-4494-ACC5-2CA0E63AD0E2

Q36728127-7803B507-5C19-456F-85C8-55F879C2ADD5

Q36728127-EF29A351-1793-4607-9C3D-E99A623A604D

P2860

Q36728127-05F10555-3AE0-4C3D-A86A-39EA1C69A55A

Q36728127-0753866E-BF8D-49F2-B9CD-3692379A51CD

Q36728127-07B1D432-0298-4C8D-A577-57A30F21E88D

Q36728127-09BEED79-AE34-4586-9520-0E8BC141AD59

Q36728127-0BA20F16-4595-4A6F-B965-EF5996FF8A20

Q36728127-1303D528-7C7C-420A-B4CB-E128D0EC28AB

Q36728127-16C6E9FF-0C07-48FE-AA7A-DDA0DD717208

Q36728127-18457F76-51BC-4A06-B382-5884C7A977D6

Q36728127-19A2CDC6-43D3-40D8-905A-840AECA81097

Q36728127-1AD05436-1345-431F-952F-D7EF3DA01DB1

P304

Q36728127-2C8373FD-4F74-489B-8BB1-B6EABA10E143

P31

Q36728127-F35C7A9A-E09F-49BE-8C8D-2DF07FC5789B

P356

Q36728127-994B4BE3-EBBD-4695-9934-1372A3374B58

P407

Q36728127-07FAA4D8-3BC8-43A8-B942-0351FCEA8517

P433

Q36728127-5AFE73A6-0F9E-4BB0-AB87-52CBF641F38F

P478

Q36728127-8A0270DB-14EB-4BF3-AF6D-3EF9A9681384

P50

Q36728127-076EEADC-A1AE-4473-B3E6-10AC0B2DDD2D

Q36728127-7F1E4ABD-C543-4FAF-91B9-AC666210277D

P577

Q36728127-80E66329-7321-4167-87FD-EC53F2835C2D

P5875

Q36728127-8839DCDC-41FA-49BB-AA6D-737ACEC60240

P698

Q36728127-A66828BC-474C-428A-BEA5-33112C03B0EA

P921

Q36728127-F7CEFDAB-87E5-4508-832D-9015994E4E55

P932

Q36728127-B1E4BACC-E261-4AE6-B654-5200538E7078

P356

J.DEVCEL.2008.02.004

P1433

Developmental Cell

P1476

Glucose restriction inhibits s ...... K-mediated regulation of Nampt

@en

P2093

Anthony A Sauve

http://www.w3.org/2001/XMLSchema#string

Eric P Hoffman

http://www.w3.org/2001/XMLSchema#string

Marcella Fulco

http://www.w3.org/2001/XMLSchema#string

Michael W McBurney

http://www.w3.org/2001/XMLSchema#string

Po Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Oral Antidiabetic Agents

Role of AMP-activated protein kinase in mechanism of metformin action

Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase

Negative control of p53 by Sir2alpha promotes cell survival under stress

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase

Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma

Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase

SIRT1 deacetylates and positively regulates the nuclear receptor LXR

Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme

Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase

P304

661-673

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DEVCEL.2008.02.004

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5375000

http://www.w3.org/2001/XMLSchema#string

P698

18477450

http://www.w3.org/2001/XMLSchema#string

P921

P932

2431467

http://www.w3.org/2001/XMLSchema#string